Examine the efficacy of brinzolamide for the treatment of central serous chorioretinopathy
Who can participate
Age range18 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Central serous chorioretinopathy (CSC) affecting the fovea, non-resolving after 4 months of follow-up
* Optical coherence tomography (OCT) shows foveal subretinal fluid
* Fluorescein angiography and indocyanine green confirm the diagnosis
Exclusion Criteria:
* Any other ophthalmic condition that may lead to subretinal fluid
* Choroidal neovascularization
* Myopia \> -6D
* Previous treatment for CSC in the past 6 months
* Known allergy to fluorescein or indocyanin green
* Known allergy for brinzolamide
* Pregnancy, breast feeding